Diiodohydroxyquinoline
Identification
- Name
- Diiodohydroxyquinoline
- Accession Number
- DB09115
- Description
Diiodohydroxyquinoline, also known as uidoquinol and iodoquinol, is a quinoline derivative that can be used in the treatment of amoebiasis. The exact mechanism of action is unknown. Iodoquinol is not currently available in any FDA-approved products.
- Type
- Small Molecule
- Groups
- Approved
- Structure
Structure for Diiodohydroxyquinoline (DB09115)
- Weight
- Average: 396.954
Monoisotopic: 396.84605 - Chemical Formula
- C9H5I2NO
- Synonyms
- Diiodohydroxyquin
- Diiodohydroxyquinoline
- Iodoquinol
- Ioquin
- External IDs
- NSC-8704
- SS-578
Pharmacology
- Indication
Used in the treatment of amoebiasis.
- Associated Conditions
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
Unknown.
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Take after a meal. This may reduce gastrointestinal irritation.
Products
Purchasing individual compounds or compound libraries for your research?
Learn More- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Unlock Additional DataDiodoquin Tab 210mg Tablet Oral Glenwood Inc. 1992-12-31 2015-06-18 Canada 
Diodoquin Tab 650mg Tablet Oral Glenwood Inc. 1992-12-31 2014-07-30 Canada Additional Data Available- Application NumberApplication NumberAvailable for Purchase
A unique ID assigned by the FDA when a product is submitted for approval by the labeller.
Learn more - Product CodeProduct CodeAvailable for Purchase
A governmentally-recognized ID which uniquely identifies the product within its regulatory market.
Learn more
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Ovoquinol Cones Diiodohydroxyquinoline (75 mg) + Sulfadiazine (400 mg) + Undecylenic acid (50 mg) Suppository Vaginal Lab Nadeau LtÉe, Division Of Technilab Inc. 1963-12-31 1999-09-28 Canada Ovoquinol Crm Vaginale Diiodohydroxyquinoline (2 %) + Sulfadiazine (8 %) + Undecylenic acid (1 %) Cream Vaginal Lab Nadeau LtÉe, Division Of Technilab Inc. 1980-12-31 1999-09-28 Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Alcortin Diiodohydroxyquinoline (1 g/100g) + Hydrocortisone (2 g/100g) Gel Topical Primus Pharmaceuticals 2003-07-25 Not applicable US 
Alcortin A Diiodohydroxyquinoline (10 mg/1g) + Aloe Vera Leaf (10 mg/1g) + Hydrocortisone acetate (20 mg/1g) Gel Topical Primus Pharmaceuticals 2010-01-01 Not applicable US Alcortin A Diiodohydroxyquinoline (10 mg/1g) + Aloe Vera Leaf (10 mg/1g) + Hydrocortisone acetate (20 mg/1g) Gel Topical Novum Pharma, Llc 2015-03-01 Not applicable US Aloquin Diiodohydroxyquinoline (12.5 mg/1g) + Aloe Vera Leaf (10 mg/1g) Gel Topical Novum Pharma, Llc 2015-03-01 2018-06-01 US Aloquin Diiodohydroxyquinoline (12.5 mg/1g) + Aloe Vera Leaf (10 mg/1g) Gel Topical Primus Pharmaceuticals 2009-07-06 Not applicable US Dermazene Diiodohydroxyquinoline (10 mg/1g) + Hydrocortisone (10 mg/1g) Cream Topical Stratus Pharmaceuticals 2001-06-11 Not applicable US Hydro-Iodoquinol Diiodohydroxyquinoline (10 mg/1g) + Hydrocortisone acetate (20 mg/1g) Gel Topical Seton Pharmaceuticals 2010-06-10 2010-10-02 US Hydrocortisone 2.5% / Iodoquinol 1% / Ketoconazole 2% Diiodohydroxyquinoline (1 g/100g) + Hydrocortisone (2.5 g/100g) + Ketoconazole (2 g/100g) Cream Topical Sincerus Florida, LLC 2019-05-17 Not applicable US Hydrocortisone Acetate, Iodoquinol Diiodohydroxyquinoline (10 mg/1g) + Hydrocortisone acetate (19 mg/1g) Cream Topical Bowyn Labs, Llc 2011-07-29 Not applicable US Hydrocortisone Iodoquinol Diiodohydroxyquinoline (10 mg/1g) + Hydrocortisone (10 mg/1g) Cream Topical Syntenza Pharmaceuticals Llc 2018-10-05 Not applicable US
Categories
- ATC Codes
- G01AC01 — Diiodohydroxyquinoline
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as haloquinolines. These are compounds containing a quinoline moiety, which is substituted at one or more ring positions by n halogen atom.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Quinolines and derivatives
- Sub Class
- Haloquinolines
- Direct Parent
- Haloquinolines
- Alternative Parents
- 8-hydroxyquinolines / P-iodophenols / O-iodophenols / Pyridines and derivatives / Aryl iodides / Heteroaromatic compounds / Azacyclic compounds / Organopnictogen compounds / Organooxygen compounds / Organonitrogen compounds show 2 more
- Substituents
- 2-iodophenol / 4-iodophenol / 8-hydroxyquinoline / Aromatic heteropolycyclic compound / Aryl halide / Aryl iodide / Azacycle / Benzenoid / Haloquinoline / Heteroaromatic compound show 9 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- quinolines (CHEBI:5950)
Chemical Identifiers
- UNII
- 63W7IE88K8
- CAS number
- 83-73-8
- InChI Key
- UXZFQZANDVDGMM-UHFFFAOYSA-N
- InChI
- InChI=1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
- IUPAC Name
- 5,7-diiodoquinolin-8-ol
- SMILES
- OC1=C2N=CC=CC2=C(I)C=C1I
References
- General References
- Not Available
- External Links
- KEGG Drug
- D00581
- KEGG Compound
- C07636
- PubChem Compound
- 3728
- PubChem Substance
- 310265032
- ChemSpider
- 3597
- BindingDB
- 66035
- 3435
- ChEBI
- 5950
- ChEMBL
- CHEMBL86754
- ZINC
- ZINC000003830942
- Drugs.com
- Drugs.com Drug Page
- Wikipedia
- Diiodohydroxyquinoline
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Topical Tablet Oral Tablet 250 mg Tablet 650 mg Tablet Vaginal 100 mg Tablet Vaginal 7 mg Cream Topical Suppository Vaginal Cream Vaginal - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0815 mg/mL ALOGPS logP 3.93 ALOGPS logP 3.69 ChemAxon logS -3.7 ALOGPS pKa (Strongest Acidic) 7.39 ChemAxon pKa (Strongest Basic) 3.34 ChemAxon Physiological Charge 0 ChemAxon Hydrogen Acceptor Count 2 ChemAxon Hydrogen Donor Count 1 ChemAxon Polar Surface Area 33.12 Å2 ChemAxon Rotatable Bond Count 0 ChemAxon Refractivity 68.69 m3·mol-1 ChemAxon Polarizability 25.9 Å3 ChemAxon Number of Rings 2 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter No ChemAxon Veber's Rule Yes ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created on September 22, 2015 11:14 / Updated on June 12, 2020 10:52
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
![]({"CS-Molecular-Health-1.jpg":"/assets/linkouts/CS-Molecular-Health-1-19e76f023997d5ac198da2cb9976457f7b9ba733f0ea8a780fe21191c759e8fa.jpg","Drug-Dev-2.jpg":"/assets/linkouts/Drug-Dev-2-7c3039d93245f493c23278efbf759e4f933848a676262d579087d5cc516af179.jpg","Drug-Search-3.jpg":"/assets/linkouts/Drug-Search-3-7346c33d2133f62b46cbfbbe2b666e78f955c6847e242692c6081fec37c4d10d.jpg","PM-3.jpg":"/assets/linkouts/PM-3-13494ac4c996d71619127a11f685681418d4280832dec162c0b2c9c8bc2eda50.jpg","OD-Webinar-1.jpg":"/assets/linkouts/OD-Webinar-1-f9357f6d57fef5e411aa1c0439ef46c86d9151214434659d096eeed6407b799b.jpg","DDI-3.jpg":"/assets/linkouts/DDI-3-12808cf864d540ad43757b10b08fc52ae93e793b0c6e81345555187b2840ad09.jpg","EMR-2.jpg":"/assets/linkouts/EMR-2-adacf8de3f42cb06d6676d06fce611c29781db6ad30776cd18b72a7d8e69f0c8.jpg","Covid.jpg":"/assets/linkouts/Covid-eed8f17668b0308db62ce3c656f5e2f562376e9185ae08dda5ce6ed9ab0bbd1f.jpg","CS-Molecular-Health-2.jpg":"/assets/linkouts/CS-Molecular-Health-2-22f41f94b3f87e44a1dcaa8f6c03dc411ab69558efd4f3148ff9bb6adaa956dc.jpg","PM-5.jpg":"/assets/linkouts/PM-5-d0dc031e0fa0d0097d912eff07b7e80b27b867264dd5b055e379a57bfa2a8723.jpg","DDI-4.jpg":"/assets/linkouts/DDI-4-313b9c374b937fd78bb2ade652b9b030abb9e6cb90efd35833f793e384e8185b.jpg","Discover-1.jpg":"/assets/linkouts/Discover-1-b48ae6a3872eeb442f4c22a9a1d867428c83a917ec78a8c3ff4e02f84c5d4fef.jpg","Discover-2.jpg":"/assets/linkouts/Discover-2-6e7759998ee0fdc234cd84eea962f2480f0c7dafadabd785924918420decb102.jpg","Repurpose-1.jpg":"/assets/linkouts/Repurpose-1-265fbec40f0eac18d51d3ec4f558c10cb623d834ea75e0296259e458b72ee6d4.jpg","Repurpose-2.jpg":"/assets/linkouts/Repurpose-2-d12bd1d18b92d36eab60e71e6fd59acf04ef60a53783570e11eef397a0e0f4f5.jpg","PM-6.jpg":"/assets/linkouts/PM-6-3ae66e41f7ae1e851a0910be89141cf2533509b46df6379464efc885d5ee2f07.jpg","Drug-Search-4.jpg":"/assets/linkouts/Drug-Search-4-2a9102bd41f16e8c40c9d8044d1dcb6f206ff80107cc269aa83d02ea683bc829.jpg","DDI-5.jpg":"/assets/linkouts/DDI-5-fa1c287946f4044094c723161577cb5ac631f9cd1217446e510dc79ace6cb94e.jpg","TH-1.jpg":"/assets/linkouts/TH-1-55a9077bb39e8c38a68c67b555b8091d21a9d41b1c21c7daed3fe53e6f9f3c97.jpg","TH-2.jpg":"/assets/linkouts/TH-2-1d488747fa4af00ab970a48dba0b228b054d166aa22c1760a310e2b72dd22589.jpg"})
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates